Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weigang Ge

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Surgery (London, England)|November 2, 2023
Risk stratification of papillary thyroid cancers using multidimensional machine learningYuanhui Li, Fan Wu, Weigang Ge, et al.
Journal of Proteome Research|November 8, 2021
Computational Optimization of Spectral Library Size Improves DIA-MS Proteome Coverage and Applications to 15 TumorsWeigang Ge, Xiao Liang, Fangfei Zhang, et al.
Cell Reports. Medicine|August 21, 2024
Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis predictionRui Sun, Jun A, Haolan Yu, et al.
Cell Reports|January 13, 2022
Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19Xiaojie Bi, Wei Liu, Xuan Ding, et al.
Cell Discovery|July 25, 2022
Enhanced inflammation and suppressed adaptive immunity in COVID-19 with prolonged RNA sheddingXiaohua Tang, Rui Sun, Weigang Ge, et al.
Computational and Structural Biotechnology Journal|June 30, 2021
Eleven routine clinical features predict COVID-19 severity uncovered by machine learning of longitudinal measurementsKai Zhou, Yaoting Sun, Lu Li, et al.
Cell|June 4, 2020
Proteomic and Metabolomic Characterization of COVID-19 Patient SeraBo Shen, Xiao Yi, Yaoting Sun, et al.
Nature Cancer|February 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi-Zhou Jiang, Ding Ma, Xi Jin, et al.
Nature|June 17, 2026
Spatial distribution of the proteome in the human body and in cancersLiang Yue, Wenhao Jiang, Sainan Li, et al.
Iscience|July 1, 2026
Proteomics and human microchips identify Thrombospondin-1 as a potential biomarker for calciphylaxis stem cell therapyJiaying Hu, Shijiu Lu, Lianju Qin, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Surgery (London, England)|November 2, 2023
Risk stratification of papillary thyroid cancers using multidimensional machine learningYuanhui Li, Fan Wu, Weigang Ge, et al.
Journal of Proteome Research|November 8, 2021
Computational Optimization of Spectral Library Size Improves DIA-MS Proteome Coverage and Applications to 15 TumorsWeigang Ge, Xiao Liang, Fangfei Zhang, et al.
Cell Reports. Medicine|August 21, 2024
Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis predictionRui Sun, Jun A, Haolan Yu, et al.
Cell Reports|January 13, 2022
Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19Xiaojie Bi, Wei Liu, Xuan Ding, et al.
Cell Discovery|July 25, 2022
Enhanced inflammation and suppressed adaptive immunity in COVID-19 with prolonged RNA sheddingXiaohua Tang, Rui Sun, Weigang Ge, et al.
Computational and Structural Biotechnology Journal|June 30, 2021
Eleven routine clinical features predict COVID-19 severity uncovered by machine learning of longitudinal measurementsKai Zhou, Yaoting Sun, Lu Li, et al.
Cell|June 4, 2020
Proteomic and Metabolomic Characterization of COVID-19 Patient SeraBo Shen, Xiao Yi, Yaoting Sun, et al.
Nature Cancer|February 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi-Zhou Jiang, Ding Ma, Xi Jin, et al.
Nature|June 17, 2026
Spatial distribution of the proteome in the human body and in cancersLiang Yue, Wenhao Jiang, Sainan Li, et al.
Iscience|July 1, 2026
Proteomics and human microchips identify Thrombospondin-1 as a potential biomarker for calciphylaxis stem cell therapyJiaying Hu, Shijiu Lu, Lianju Qin, et al.
Pageof 5